Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
resveratrol
- Development stage
- Phase 4
- Lead developer
- GSK
- Modality
- Small Molecules
- Administration
- Oral, Topical, Intravenous
01
Overview
Resveratrol is a natural polyphenolic compound belonging to the stilbenoid group, commonly found in grapes, wine, peanuts, and Japanese knotweed (*Polygonum cuspidatum*). It functions as a calorie restriction mimetic, primarily known for activating **Sirtuin 1 (SIRT1)** and **AMP-activated protein kinase (AMPK)**, which subsequently improves mitochondrial function, enhances insulin sensitivity, and reduces oxidative stress. Resveratrol has been extensively investigated for its cardioprotective, anti-inflammatory, and neuroprotective properties. Clinical development spans various indications including obesity, metabolic syndrome, hypertriglyceridemia, and type 2 diabetes. Additionally, it is used as an excipient/matrix in medical devices, such as the SeQuent Please ReX drug-coated balloon, to facilitate the delivery of antiproliferative drugs.
- Brand names
- resVidaVERI-TE Resveratrol
- Other names
- trans-resveratroltrans-3,5,4'-trihydroxystilbenePolyphenolStilbenoid白藜芦醇
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NF-κBPPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on resveratrol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on resveratrol.